feed,title,long_url,short_url
Motley,Is Ocugen's Surge Much Ado About Nothing?,https://www.fool.com/investing/2021/11/05/is-ocugens-surge-much-ado-about-nothing/?source=iedfolrf0000001,https://j.mp/3k9pjj4
Motley,3 Reasons Why Investors Should Love Regeneron's Q3 Update,https://www.fool.com/investing/2021/11/05/3-reasons-why-investors-should-love-regenerons-q3/?source=iedfolrf0000001,https://j.mp/3k8b7Ha
Motley,Can Vertex Make Billions With a New Game-Changing Treatment? The Answer May Be Just Ahead,https://www.fool.com/investing/2021/11/05/can-vertex-make-billions-with-a-new-game-changer/?source=iedfolrf0000001,https://j.mp/3whDwPV
